As of 2024-12-14, the Relative Valuation of Corline Biomedical AB (CLBIO.ST) is (10.19) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 8.28 SEK, the upside of Corline Biomedical AB based on Relative Valuation is -223.0%.
The range of the Relative Valuation is (8.90) - (10.66) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 30.7x | 23.0x |
| Forward P/E multiples | 19.9x - 23.8x | 22.4x |
| Fair Price | (8.90) - (10.66) | (10.19) |
| Upside | -207.5% - -228.7% | -223.0% |
| Date | P/E |
| 2024-12-10 | -17.09 |
| 2024-12-09 | -16.64 |
| 2024-12-06 | -16.46 |
| 2024-12-05 | -16.46 |
| 2024-12-04 | -15.75 |
| 2024-12-03 | -16.15 |
| 2024-12-02 | -15.79 |
| 2024-11-29 | -14.95 |
| 2024-11-28 | -13.70 |
| 2024-11-27 | -14.28 |
| 2024-11-26 | -14.28 |
| 2024-11-25 | -13.97 |
| 2024-11-22 | -14.32 |
| 2024-11-21 | -14.72 |
| 2024-11-20 | -15.44 |
| 2024-11-19 | -14.63 |
| 2024-11-18 | -14.46 |
| 2024-11-15 | -14.95 |
| 2024-11-14 | -15.17 |
| 2024-11-13 | -14.72 |
| 2024-11-12 | -15.44 |
| 2024-11-11 | -15.66 |
| 2024-11-08 | -14.10 |
| 2024-11-07 | -15.17 |
| 2024-11-06 | -15.84 |
| 2024-11-04 | -17.80 |
| 2024-11-01 | -17.85 |
| 2024-10-31 | -17.89 |
| 2024-10-30 | -17.53 |
| 2024-10-29 | -17.09 |
| 2024-10-28 | -17.89 |
| 2024-10-25 | -18.96 |
| 2024-10-24 | -17.98 |
| 2024-10-23 | -17.58 |
| 2024-10-22 | -17.04 |
| 2024-10-21 | -17.13 |
| 2024-10-18 | -17.18 |
| 2024-10-17 | -17.18 |
| 2024-10-16 | -17.36 |
| 2024-10-15 | -17.18 |
| 2024-10-14 | -18.34 |
| 2024-10-11 | -18.47 |
| 2024-10-10 | -19.01 |
| 2024-10-09 | -20.08 |
| 2024-10-07 | -20.17 |
| 2024-10-04 | -20.21 |
| 2024-10-03 | -18.96 |
| 2024-10-02 | -18.96 |
| 2024-10-01 | -18.38 |
| 2024-09-30 | -18.83 |